Ninety One (UK)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-340,111
Closed -$55.1M 191
2022
Q1
$55.1M Sell
340,111
-428,002
-56% -$62.2M 0.14% 112
2021
Q4
$104M Sell
768,113
-249,857
-25% -$29.5M 0.25% 90
2021
Q3
$110M Sell
1,017,970
-65,129
-6% -$7.44M 0.28% 87
2021
Q2
$122M Buy
1,083,099
+40,896
+4% +$4.61M 0.32% 85
2021
Q1
$113M Sell
1,042,203
-100,611
-9% -$10.8M 0.32% 85
2020
Q4
$122M Buy
1,142,814
+11,145
+1% +$1.07M 0.38% 72
2020
Q3
$99.1M Sell
1,131,669
-58,648
-5% -$5.52M 0.36% 70
2020
Q2
$117M Buy
1,190,317
+1,929
+0.2% +$170K 0.41% 61
2020
Q1
$90.5M Buy
1,188,388
+586,850
+98% +$50M 0.38% 61
2019
Q4
$53.3M Buy
+601,538
New +$49.9M 0.18% 99
2018
Q2
Sell
-43,661
Closed -$4.13M 260
2018
Q1
$4.13M Sell
43,661
-97,741
-69% -$10.7M 0.02% 201
2017
Q4
$13.7M Sell
141,402
-51,330
-27% -$4.84M 0.06% 171
2017
Q3
$17.1M Sell
192,732
-17,599
-8% -$1.34M 0.08% 157
2017
Q2
$15.3M Buy
210,331
+43,353
+26% +$2.91M 0.07% 152
2017
Q1
$10.9M Buy
166,978
+5,801
+4% +$365K 0.05% 182
2016
Q4
$10.1M Sell
161,177
-16,421
-9% -$1M 0.05% 171
2016
Q3
$11.2M Buy
177,598
+19,940
+13% +$1.29M 0.05% 183
2016
Q2
$9.76M Sell
157,658
-31,565
-17% -$1.92M 0.05% 192
2016
Q1
$10.8M Sell
189,223
-54,959
-23% -$3.06M 0.06% 182
2015
Q4
$14.5M Sell
244,182
-3,556
-1% -$205K 0.08% 151
2015
Q3
$13.5M Sell
247,738
-13,657
-5% -$889K 0.08% 154
2015
Q2
$17.6M Buy
261,395
+21,941
+9% +$1.43M 0.1% 148
2015
Q1
$14M Buy
239,454
+11,250
+5% +$680K 0.08% 164
2014
Q4
$14.9M Buy
228,204
+6,454
+3% +$407K 0.09% 159
2014
Q3
$12.8M Buy
221,750
+18,661
+9% +$1.04M 0.08% 163
2014
Q2
$11.5M Buy
203,089
+49,920
+33% +$2.62M 0.07% 171
2014
Q1
$7.87M Buy
153,169
+97,629
+176% +$4.93M 0.05% 170
2013
Q4
$2.93M Buy
55,540
+2,125
+4% +$104K 0.02% 177
2013
Q3
$2.39M Buy
53,415
+7,446
+16% +$330K 0.02% 197
2013
Q2
$1.9M Buy
+45,969
New +$2.01M 0.01% 205

Other funds holding ABBV